Suzanne E. Mahady

2.3k total citations
25 papers, 709 citations indexed

About

Suzanne E. Mahady is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Suzanne E. Mahady has authored 25 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Hepatology. Recurrent topics in Suzanne E. Mahady's work include Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (6 papers) and Liver Disease and Transplantation (5 papers). Suzanne E. Mahady is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (6 papers) and Liver Disease and Transplantation (5 papers). Suzanne E. Mahady collaborates with scholars based in Australia, United States and Brazil. Suzanne E. Mahady's co-authors include Jacob George, Leon A. Adams, Sarah Walker, Arun J. Sanyal, Angela C Webster, Jonathan C. Craig, Finlay Macrae, David John, Karen Canfell and Xue Qin Yu and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Suzanne E. Mahady

23 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne E. Mahady Australia 13 439 218 209 119 117 25 709
Peter Konyn United States 14 567 1.3× 357 1.6× 171 0.8× 116 1.0× 132 1.1× 15 834
Rajasekhara R. Mummadi United States 11 580 1.3× 310 1.4× 193 0.9× 249 2.1× 94 0.8× 26 816
Shahid M. Malik United States 17 534 1.2× 385 1.8× 127 0.6× 279 2.3× 100 0.9× 49 946
Raxitkumar Jinjuvadia United States 11 368 0.8× 218 1.0× 85 0.4× 72 0.6× 151 1.3× 24 600
Saumya Jayakumar Canada 10 648 1.5× 483 2.2× 169 0.8× 233 2.0× 64 0.5× 18 1.0k
Preya Patel Australia 15 458 1.0× 351 1.6× 118 0.6× 98 0.8× 80 0.7× 41 669
Konstantinos Kargiotis Greece 7 522 1.2× 213 1.0× 343 1.6× 206 1.7× 83 0.7× 7 720
Gregorio Castellano Spain 15 771 1.8× 409 1.9× 229 1.1× 139 1.2× 80 0.7× 28 1.1k
Dawn M. Emick United States 6 786 1.8× 471 2.2× 334 1.6× 260 2.2× 120 1.0× 7 1.2k
Juanwen Zhang China 12 230 0.5× 83 0.4× 103 0.5× 92 0.8× 44 0.4× 25 503

Countries citing papers authored by Suzanne E. Mahady

Since Specialization
Citations

This map shows the geographic impact of Suzanne E. Mahady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Mahady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Mahady more than expected).

Fields of papers citing papers by Suzanne E. Mahady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne E. Mahady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Mahady. The network helps show where Suzanne E. Mahady may publish in the future.

Co-authorship network of co-authors of Suzanne E. Mahady

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne E. Mahady. A scholar is included among the top collaborators of Suzanne E. Mahady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne E. Mahady. Suzanne E. Mahady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Darrick K., David Cheng, Anna L. Parks, et al.. (2025). Functional disability after clinically significant extracranial bleeding: a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) Trial. Journal of Thrombosis and Haemostasis. 23(5). 1507–1515. 1 indexed citations
2.
Mahady, Suzanne E., Lê Thị Phương Thảo, Robyn L. Woods, et al.. (2023). Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial. Kidney International Reports. 8(4). 737–745. 9 indexed citations
3.
Mehta, Raaj S., Bharati Kochar, Zhen Zhou, et al.. (2023). Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study. Gastroenterology. 165(3). 564–572.e1. 11 indexed citations
4.
Downie, Jonathan M., Moeen Riaz, Jing Xie, et al.. (2022). Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts. Cancer Prevention Research. 15(8). 509–519.
5.
Jachno, Kim, Stéphane Héritier, Robyn L. Woods, et al.. (2022). Examining evidence of time-dependent treatment effects: an illustration using regression methods. Trials. 23(1). 857–857. 3 indexed citations
6.
Mahady, Suzanne E., Karen L. Margolis, Andrew T. Chan, et al.. (2020). Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial. Gut. 70(4). 717–724. 76 indexed citations
7.
Adams, Leon A., Stuart K. Roberts, Simone I. Strasser, et al.. (2020). Nonalcoholic fatty liver disease burden: Australia, 2019–2030. Journal of Gastroenterology and Hepatology. 35(9). 1628–1635. 85 indexed citations
8.
Margolis, Karen L., Suzanne E. Mahady, Mark Nelson, et al.. (2018). Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial. Contemporary Clinical Trials Communications. 11. 30–36. 15 indexed citations
9.
Mahady, Suzanne E. & Leon A. Adams. (2018). Burden of non‐alcoholic fatty liver disease in Australia. Journal of Gastroenterology and Hepatology. 33(S1). 1–11. 37 indexed citations
10.
Feletto, Eleonora, Xue Qin Yu, Jie‐Bin Lew, et al.. (2018). Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases. Cancer Epidemiology Biomarkers & Prevention. 28(1). 83–90. 93 indexed citations
11.
Mahady, Suzanne E., Petra Macaskill, Jonathan C. Craig, et al.. (2017). Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis. Clinical Gastroenterology and Hepatology. 15(9). 1453–1460.e1. 40 indexed citations
12.
Mahady, Suzanne E. & Jacob George. (2015). Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism. 65(8). 1172–1182. 50 indexed citations
13.
Mahady, Suzanne E., Timothy E. Schlub, Lisa Bero, et al.. (2014). Side effects are incompletely reported among systematic reviews in gastroenterology. Journal of Clinical Epidemiology. 68(2). 144–153. 14 indexed citations
14.
Tong, Allison, et al.. (2014). Radiologists’ perspectives about evidence-based medicine and their clinical practice: a semistructured interview study. BMJ Open. 4(12). e006199–e006199. 8 indexed citations
15.
Mahady, Suzanne E. & Jacob George. (2012). The Future Liver of the Asia Pacific: Fatter and Firmer from More Fructose and Fortune?. Journal of Clinical and Experimental Hepatology. 3(2). 106–113. 9 indexed citations
16.
Mahady, Suzanne E. & Jacob George. (2012). Management of Nonalcoholic Steatohepatitis. Clinics in Liver Disease. 16(3). 631–645. 34 indexed citations
17.
Mahady, Suzanne E., Germaine Wong, Jonathan C. Craig, & Jacob George. (2012). Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis. Hepatology. 56(6). 2172–2179. 38 indexed citations
18.
Mahady, Suzanne E., Angela C Webster, Sarah Walker, Arun J. Sanyal, & Jacob George. (2011). The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis. Journal of Hepatology. 55(6). 1383–1390. 132 indexed citations
19.
Mahady, Suzanne E., Patrick Fitzgerald, David J. Koorey, et al.. (2010). Locoregional therapies for hepatocellular carcinoma: Which patients are most likely to gain a survival advantage?. Journal of Gastroenterology and Hepatology. 25(7). 1299–1305. 5 indexed citations
20.
Mahady, Suzanne E., Alan Moss, & Vu Kwan. (2010). EUS-guided drainage of a mediastinal collection complicating FNA of a bronchogenic cyst. Gastrointestinal Endoscopy. 73(6). 1306–1308. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Konyn Breakdown of academic impact, for papers by Rajasekhara R. Mummadi Breakdown of academic impact, for papers by Shahid M. Malik Breakdown of academic impact, for papers by Raxitkumar Jinjuvadia Breakdown of academic impact, for papers by Saumya Jayakumar Breakdown of academic impact, for papers by Preya Patel Breakdown of academic impact, for papers by Konstantinos Kargiotis Breakdown of academic impact, for papers by Gregorio Castellano Breakdown of academic impact, for papers by Dawn M. Emick Breakdown of academic impact, for papers by Juanwen Zhang
Rankless by CCL
2026